anmelden
AstraZeneca Aktie
151,60
EUR
-0,75
EUR
-0,49
%
152,20
EUR
+0,65
EUR
+0,43
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 27.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.07.20 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 21.07.20 | AstraZeneca Sell | UBS AG | |
| 21.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 25.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.06.20 | AstraZeneca Reduce | Oddo BHF | |
| 19.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.06.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 08.06.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.06.20 | AstraZeneca Sell | UBS AG | |
| 08.06.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 04.06.20 | AstraZeneca Sell | UBS AG | |
| 02.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.06.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.05.20 | AstraZeneca Sell | UBS AG | |
| 25.05.20 | AstraZeneca Sell | UBS AG | |
| 22.05.20 | AstraZeneca Sell | UBS AG | |
| 20.05.20 | AstraZeneca overweight | Barclays Capital | |
| 15.05.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.05.20 | AstraZeneca overweight | Barclays Capital | |
| 01.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.04.20 | AstraZeneca Reduce | HSBC | |
| 29.04.20 | AstraZeneca Sell | UBS AG | |
| 29.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 23.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.04.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 17.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 15.04.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.04.20 | AstraZeneca buy | Deutsche Bank AG | |
| 14.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.04.20 | AstraZeneca overweight | Barclays Capital | |
| 07.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 06.04.20 | AstraZeneca buy | Deutsche Bank AG | |
| 03.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 31.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 31.03.20 | AstraZeneca buy | Oddo BHF | |
| 30.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.03.20 | AstraZeneca buy | Deutsche Bank AG | |
Werbung
Werbung